Drug
Azilsartan Trimethylethanolamine
Azilsartan Trimethylethanolamine: highest development phase Phase 1, developed by Hansoh Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Hansoh Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Azilsartan Trimethylethanolamine NCT01985152 | Phase 1 | Health |
Latest
No recent events.
Follow Azilsartan Trimethylethanolamine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.